Postirradiation sarcomas are an unusual but well-recognized late effect of cancer therapy.

Objective: to assess the efficacy of gemcitabine in patients with a Variety of advanced soft tissue Sarcomas that have failed to respond or escaped Adriamycin - and ifosfamide - based chemotherapy.